Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BRIGATINIB Cause C-reactive protein increased? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of C-reactive protein increased have been filed in association with BRIGATINIB (Alunbrig). This represents 0.2% of all adverse event reports for BRIGATINIB.

7
Reports of C-reactive protein increased with BRIGATINIB
0.2%
of all BRIGATINIB reports
2
Deaths
5
Hospitalizations

How Dangerous Is C-reactive protein increased From BRIGATINIB?

Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does BRIGATINIB Cause?

Death (405) Non-small cell lung cancer (370) Off label use (256) Diarrhoea (239) Metastases to central nervous system (219) Nausea (218) Lung neoplasm malignant (216) Fatigue (201) Blood creatine phosphokinase increased (198) Product dose omission issue (193)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which BRIGATINIB Alternatives Have Lower C-reactive protein increased Risk?

BRIGATINIB vs BRILINTA BRIGATINIB vs BRILIQUE BRIGATINIB vs BRIMONIDINE BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE BRIGATINIB vs BRIMONIDINE\TIMOLOL

Related Pages

BRIGATINIB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased BRIGATINIB Demographics